7 trends tracked about this subject — the full history, oldest to newest below.
A common arthritis medication, Upadacitinib, has demonstrated the ability to restore up to 100% of hair in patients suffering from severe alopecia areata.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A global trial reveals that the arthritis medication Upadacitinib can restore significant hair growth in patients suffering from severe alopecia areata.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Upadacitinib, a medication originally used for arthritis, has demonstrated efficacy in promoting hair regrowth for patients with severe alopecia areata.
Q32 Bio (QTTB) shares surged following positive phase 2 clinical trial results for its alopecia areata drug, Bempikibart.